Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

MEDP

+ Watchlist+ Portfolio

Medpace Holdings, Inc.

Regulated industrySells to businessesTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$646.87
52-Week Range
$373.00 – $693.97
Market Cap
$17.73B
P/E (TTM)
35.20
EPS (TTM)
18.01
Dividend Yield
0.00%
Advanced Metrics
Price/Book
30.31
PEG Ratio
3.36
Return on Equity
117.88%
Return on Assets
18.71%
Gross Margin
72.24%
Operating Margin
21.39%
Profit Margin
18.24%
Current Ratio
0.83
Debt/Equity
0.29
Total Debt
$171.46M
Free Cash Flow
$497.78M
Revenue Growth
8.50%
Earnings Growth
25.40%
Enterprise Value
$17.56B

Market Snapshot

About

Medpace Holdings, Inc. is a global contract research organization (CRO) providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company offers full-service clinical development support from Phase I through Phase IV, along with laboratory and imaging services.